Names | |
---|---|
IUPAC name
2-Amino-4-sulfanylbutanoic acid
|
|
Identifiers | |
454-29-5 (racemate) 6027-13-0 (L-isomer) |
|
3D model (Jmol) | Interactive image |
ChEBI | CHEBI:17230 |
ChEMBL | ChEMBL310604 |
ChemSpider | 757 |
ECHA InfoCard | 100.006.567 |
EC Number | 207-222-9 |
KEGG | C05330 |
PubChem | 778 |
UNII |
S7IJP4A89K (racemate) 0LVT1QZ0BA (L-isomer) |
|
|
|
|
Properties | |
C4H9NO2S | |
Molar mass | 135.18 g/mol |
Appearance | White crystalline powder |
Melting point | 234–235 °C (453–455 °F; 507–508 K) (decomposes) |
soluble | |
log P | -2.56 |
Acidity (pKa) | 2.25 |
Hazards | |
GHS pictograms | |
GHS signal word | Warning |
H302 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
what is ?) | (|
Infobox references | |
Homocysteine /ˌhoʊmoʊˈsɪstiːn/ is a non-protein α-amino acid. It is a homologue of the amino acid cysteine, differing by an additional methylene bridge (-CH2-). It is biosynthesized from methionine by the removal of its terminal Cεmethyl group. Homocysteine can be recycled into methionine or converted into cysteine with the aid of certain B-vitamins.
A high level of homocysteine in the blood (hyperhomocysteinemia) makes a person more prone to endothelial cell injury, which leads to inflammation in the blood vessels, which in turn may lead to atherogenesis, which can result in ischemic injury. Hyperhomocysteinemia is therefore a possible risk factor for coronary artery disease. Coronary artery disease occurs when an atherosclerotic plaque blocks blood flow to the coronary arteries, which supply the heart with oxygenated blood.
Hyperhomocysteinemia has been correlated with the occurrence of blood clots, heart attacks and strokes, though it is unclear whether hyperhomocysteinemia is an independent risk factor for these conditions. Hyperhomoscyteinemia has also been associated with early pregnancy loss and with neural tube defects.